Hemostatic defects in cancer patients. - Wikidata - awgldk - TriplyDB

Hemostatic defects in cancer patients.

Hemostatic defects in cancer patients.

http://www.wikidata.org/entity/Q39127942

about

D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival.

P2860

Q37249949-3B735B14-5003-4AF2-9146-D1C14E6026CC

P2860

Hemostatic defects in cancer patients.

http://www.wikidata.org/entity/Q39127942

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Hemostatic defects in cancer patients.

@en

Hemostatic defects in cancer patients.

@nl

type

label

Hemostatic defects in cancer patients.

@en

Hemostatic defects in cancer patients.

@nl

prefLabel

Hemostatic defects in cancer patients.

@en

Hemostatic defects in cancer patients.

@nl

P1433

Q39127942-2C616FCE-928F-4E6A-8999-10415DA94883

P1476

Q39127942-38BA165C-FAE4-4213-A958-0D5D7DCC8007

P2093

Q39127942-A0690F72-F376-40AE-858E-9B2E3D7DD96E

P2860

Q39127942-03C3DFDE-B788-49D5-879F-067CC21DA642

Q39127942-0B2F8A6F-0DE4-4D92-80D6-F08307F061BE

Q39127942-0FE85053-F4B0-427B-A945-57F5C91171EA

Q39127942-1124251F-3EF7-4E7B-91B5-262A61550416

Q39127942-1243C5E9-CB50-4640-89C3-640E2DDEF6E0

Q39127942-1454CF7A-8F3A-47F4-99F1-2E87C52132C4

Q39127942-15EE085B-0F16-4EC9-9DC5-D0F9ABE4DFE4

Q39127942-16DA54F9-EF9A-4913-9000-CE0BE7E12943

Q39127942-1850E14B-929C-429A-8D48-5D7195FC2A12

Q39127942-19EE9536-D8BD-46FD-9688-1A5673E81792

P304

Q39127942-0109BC97-1211-48A5-8ADF-E3E600A00AA0

P31

Q39127942-2AF70F2C-2A29-474A-B645-B2DFDB96E93A

P356

Q39127942-C421E4F5-EE53-4AFB-AAA1-623E7B84D2E8

P433

Q39127942-C00C6A13-FCCD-41DA-A074-04066D2F401E

P478

Q39127942-57293F2A-E97D-4959-981D-0B2C053E06BC

P577

Q39127942-90ABDCF7-5726-43A1-9A00-083DEDFF72DA

P698

Q39127942-082676BA-11E0-4991-A46F-348DB9BB159F

P356

07357909709018914

P1433

Cancer Investigation

P1476

Hemostatic defects in cancer patients.

@en

P2093

Kempin SJ

http://www.w3.org/2001/XMLSchema#string

P2860

Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity

The role of splenic irradiation in chronic lymphocytic leukemia.

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.

Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis.

Transfusions of fresh platelet concentrates to patients with secondary thrombocytopenia.

Acquired platelet dysfunction following mithramycin therapy.

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement.

Anagrelide: a new drug for treating thrombocytosis.

Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate.

P304

23-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07357909709018914

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9028387

http://www.w3.org/2001/XMLSchema#string